IRENE MUCHAI: Open Payments
NPI 1003491119 · LAWRENCE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,254 in 45 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $174 · 2025 $1,254
Food & beverage: $1,155Education: $99
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $471 |
| Vanda Pharmaceuticals Inc. | 14 | $225 |
| ABBVIE INC. | 5 | $202 |
| Lundbeck LLC | 4 | $94 |
| E.R. Squibb & Sons, L.L.C. | 3 | $87 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Alkermes, Inc. | 1 | $29 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $26 |
| Corium, LLC | 1 | $18 |
Products named: CAPLYTA, FANAPT, VRAYLAR, REXULTI, COBENFY, AUSTEDO XR, ARISTADA, Azstarys.
Industry payments across MA — which companies pay providers there.
